Skip to main content
Premium Trial:

Request an Annual Quote

Atossa Genetics Lab Gains CLIA Certification

NEW YORK (GenomeWeb News) – Breast cancer diagnostics developer Atossa Genetics said today that its breast health reference lab has received Clinical Laboratory Improvement Amendments certification from the Centers for Medicare and Medicaid Services.

The company's National Reference Laboratory for Breast Health subsidiary, located in Seattle, was certified after an inspection of its facilities, processes, and personnel, and a review of the validation and clinical reports from its lab-developed tests, and the ForeCyte and ArgusCyte Breast Health Tests.

The company's tests use molecular and cellular biomarkers for breast cancer risk, and are based on its Mammary Aspirate Specimen Cytology system, which enables nurses or physician assistants to collect samples in around 10 minutes.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.